Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

NI-0401 in Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00630643 Org: User:
Start: 01/31/06 End: 12/31/07 Due: 12/31/08

NI-0401 in Patients With Acute Renal Allograft Rejection

Phase: N/A Priority: Normal
NCT ID: NCT00805909 Org: User:
Start: 08/31/07 End: 01/31/09 Due: 01/31/10

Study of an Anti-TLR4 mAb in Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03241108 Org: User:
Start: 05/10/17 End: 06/20/18 Due: 06/20/19

Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody

Phase: N/A Priority: Normal
NCT ID: NCT01430429 Org: User:
Start: - End: - Due: -

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05403554 Org: User:
Start: 04/29/22 End: 09/30/26 Due: 09/30/27

First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01808469 Org: User:
Start: 11/30/12 End: 03/31/14 Due: 03/31/15

A Study of NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06663839 Org: User:
Start: 04/12/24 End: 01/31/26 Due: 01/31/27

First in Human Study of NI-0701 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01255501 Org: User:
Start: - End: - Due: -

NI-0801 in Allergic Contact Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01244607 Org: User:
Start: - End: - Due: -